Search
Filter by Topic
- (-) Remove Technologies filter Technologies
- Reproduction (16) Apply Reproduction filter
- People (8) Apply People filter
- Ethics (4) Apply Ethics filter
- Processes (4) Apply Processes filter
- Experiments (3) Apply Experiments filter
- Legal (3) Apply Legal filter
- Organizations (3) Apply Organizations filter
- Disorders (2) Apply Disorders filter
- Theories (2) Apply Theories filter
- Places (1) Apply Places filter
Filter by Format
- (-) Remove Articles filter Articles
Gardasil HPV Vaccination Series
In 2006, United States pharmaceutical company Merck released the Gardasil vaccination series, which protected recipients against four strains of Human Papillomaviruses, or HPV. HPV is a sexually transmitted infection which may be asymptomatic or cause symptoms such as genital warts, and is linked to cervical, vaginal, vulvar, anal, penile, head, neck, and face cancers.
Format: Articles
Subject: Technologies
Cervarix HPV Vaccination Series
In 2011, United Kingdom pharmaceutical company GlaxoSmithKline released Cervarix, a vaccination series protecting girls and women from two strains of Human Papillomavirus, or HPV. HPV, a sexually transmitted infection, can present in men and women without symptoms, or may cause symptoms such as genital warts. There is a link between HPV and cervical, vaginal, anal, head, neck, and face cancers, and Cervarix can reduce genital cancers in girls and women, particularly cervical cancer.
Format: Articles
Subject: Technologies
Frazer v. Schlegel (2007)
On 20 August 2007, in Frazer v. Schlegel, the United States Court of Appeals for the Federal Circuit decided that researchers Ian Frazer and Jian Zhou owned the rights to the vaccine patent for Human Papillomavirus, or HPV, instead of a research team led by Richard Schlegel. Frazer v. Schlegel reversed the decision that the Board of Patent Appeals and Interferences had previously made, awarding the patent to Schlegel on the basis that Frazer’s patent application contained inaccurate science.
Format: Articles
Subject: Legal, Technologies
A plant genetically modified that accumulates Pb is especially promising for phytoremediation (2003), by Carmina Gisbert et al.
In 2003, Carmina Gisbert and her research team produced a tobacco plant that could remove lead from soil. To do so, they inserted a gene from wheat plants that produces phytochelatin synthase into a shrub tobacco plant (Nicotiana glauca) to increase N. glauca's absorption and tolerance of toxic metals, particularly lead and cadmium. Gisbert and her team aimed to genetically modify a plant so that it could be used for phytoremediation- using plants to remove toxic substances from the soil.
Format: Articles
Subject: Experiments, Technologies
The Aschheim-Zondek Test for Pregnancy
Throughout history many different methods have been devised for the early detection of pregnancy. From the time of the Ancient Egyptians, inspection of the urine has been a popular place to start. However, it was not until the discovery of hormones in the early twentieth century that the development of truly reliable pregnancy tests occurred. Prior to 1978, when the first home pregnancy tests became available in the United States, pregnancy testing was done in hospital laboratories using various methods, one of them being the Aschheim-Zondek, or A-Z test.
Format: Articles
Subject: Technologies, Reproduction
Diethylstilbestrol (DES) in the US
Diethylstilbestrol (DES) is an artificially created hormone first synthesized in the late 1930s. Doctors widely prescribed DES first to pregnant women to prevent miscarriages, and later as an emergency contraceptive pill and to treat breast cancer. However, in 1971, physicians showed a link between DES and vaginal cancer during puberty in the children of women who had taken DES while pregnant. Consequently, the US Food and Drug Administration (FDA) banned its use during pregnancy.
Format: Articles
Subject: Reproduction, Technologies
Stanley Paul Leibo (1937–2014)
Stanley Paul Leibo studied the cryopreservation of embryos in the US in the twentieth century. Cryopreservation is a method of preserving biological material through freezing. Early in his career, Leibo collaborated with other scientists to study why cells were oftentimes injured during freezing. Later, Leibo and his team accomplished one of the first successful births using previously-frozen mammalian embryos.
Format: Articles
Subject: People, Technologies
Multiplex Automated Genome Engineering (MAGE)
Multiplex Automated Genome Engineering, or MAGE, is a genome editing technique that enables scientists to quickly edit an organism’s DNA to produce multiple changes across the genome. In 2009, two genetic researchers at the Wyss Institute at Harvard Medical School in Boston, Massachusetts, Harris Wang and George Church, developed the technology during a time when researchers could only edit one site in an organism’s genome at a time.
Format: Articles
Subject: Technologies, Processes
Nuclear Magnetic Resonance Imaging to Visualize Fetal Abnormalities
Nuclear magnetic resonance imaging (MRI) is a technique to create a three-dimensional image of a fetus. Doctors often use MRIs to image a fetuses after an ultrasound has detected an, or has been inconclusive about an, abnormality. In 1983 researchers in Scotland first used MRI to visualize a fetus. MRIs showed a greater level of fetal detail than ultrasound images, and researchers recognized the relevance of this technique as a means to gather information about fetal development and growth.
Format: Articles
Subject: Technologies, Technologies, Reproduction
Magnetic Resonance Microscopy (MRM)
Magnetic Resonance Microscopy (MRM) is an imaging method that allows the visualization of internal body structures. Using powerful magnets to send energy into cells, MRM picks up signals from inside a specimen and translates them into detailed computer images. MRM is a useful tool for scientists because of its ability to generate digital slices of scanned specimens that can be constructed into virtual 3D images without destroying the specimens. MRM has become an increasingly prevalent imaging technique in embryological studies.
Format: Articles
Subject: Technologies
Hysterectomy
A hysterectomy is the surgical removal of a woman's uterus. For many women, a hysterectomy comes as a solution to health problems as diverse as abnormal bleeding to reproductive cancers. First performed in the early 1800s, this procedure has evolved in terms of both technique and popularity. The first successful abdominal hysterectomy was performed by Ellis Burnham in Lowell, Massachusetts, in 1853, although earlier attempts were made in the 1840s.
Format: Articles
Subject: Technologies, Reproduction
Hormone Releasing Intrauterine Devices
Hormone releasing intrauterine devices or hormonal IUDs are contraceptive devices placed in a woman’s uterus to prevent pregnancy by continuously releasing a low dose of certain hormones. Jouri Valter Tapani Luukkainen, a medical researcher at the University of Helsinki, introduced the first hormonal IUD in 1976. Luukkainen’s IUD was a plastic device shaped like a capital T.
Format: Articles
Subject: Technologies
Amniocentesis
Amniocentesis is a test used for prenatal diagnosis of inherited diseases, Rh incompatibility, neural tube defects, and lung maturity. Normally performed during the second trimester of a pregnancy, this invasive procedure allows the detection of health problems in the fetus as early as fifteen weeks gestation. Although amniocentesis does carry some significant risks, the medical community commonly accepts it as a safe and useful procedure.
Format: Articles
Subject: Technologies, Reproduction
Oral Glucose Tolerance Test for Gestational Diabetes
In the twentieth century, researchers developed the oral glucose tolerance test, or OGTT, as a method to diagnose different types of diabetes, a medical condition that causes blood sugar levels to become abnormally high. During the test, a healthcare provider measures a person’s blood sugar levels before and after the person consumes a predetermined amount of glucose solution. While not exclusively used for pregnant women, an OGTT may test for gestational diabetes which, according to the International Diabetes Federation, affected one in six pregnancies worldwide in 2019.
Format: Articles
Subject: Technologies, Reproduction, Experiments
The Whelan Method of Sex Selection
The Whelan Method of Sex Selection is a method for increasing a couple’s probability of conceiving an infant of the desired sex through timing intercourse. Elizabeth Whelan, a public health researcher, suggested that couples only have intercourse at specific times during the woman’s menstrual cycle based on whether they wanted a female or male infant. Whelan published her method in her book, Boy or Girl, in 1977.
Format: Articles
Subject: Technologies
Pregnancy Tests
Throughout history methods involving urine have been a popular way to test for pregnancy. Early ideas ranged from simply observing the color of a woman's urine to the notion that the urine of pregnant women contains special crystals or secretions. Indeed, pregnancy testing can be traced back to 1350 BCE in Ancient Egypt. A written document from the time describes a process in which a woman would urinate on wheat and barley seeds over several days and, depending on which plant grew, both the woman's pregnancy status and the sex of the fetus could be determined.
Format: Articles
Subject: Technologies, Reproduction
Harold Delf Gillies (1882-1960)
Harold Delf Gillies performed one of the first sexual reassignment surgeries, termed gender affirmation surgeries as of 2022, on record in 1946 in London, England. He also practiced modern plastic surgery and helped distinguish it as a new branch of medicine in London, England, starting in the early 1900s. Gillies’s work focused initially on facial reconstructive surgery, particularly during both World War I and World War II. Gillies created newer and more efficient techniques that later became standard procedures for reconstructive and cosmetic surgeries.
Format: Articles
Subject: People, Technologies
Transvaginal Ultrasound-Guided Oocyte Retrieval
Transvaginal ultrasound-guided oocyte retrieval, also known as egg retrieval, is a surgical technique used by medical professionals to extract mature eggs directly from the women’s ovaries under the guidance of ultrasound imaging. In 1982, physicians Suzan Lenz and Jorgen Lauritsen at the University of Copenhagen in Copenhagen, Denmark, proposed the technology to improve the egg collection aspect of in vitro fertilization, or IVF. During IVF, a healthcare practitioner must remove mature eggs from a woman’s ovaries to fertilize them with sperm outside of the body.
Format: Articles
Subject: Technologies, Reproduction
The Game of Life, by John Horton Conway
The Game of Life, or just Life, is a one-person game that was created by the English mathematician John Horton Conway in the late 1960s. It is a simple representation of birth, death, development, and evolution in a population of living organisms, such as bacteria. Martin Gardner popularized the Game of Life by writing two articles for his column "Mathematical Games" in the journal Scientific American in 1970 and 1971. There exist several websites that provide the Game of Life as a download or as an online game.
Format: Articles
Subject: Technologies
Ooplasmic Transfer Technology
Ooplasmic transfer, also called cytoplasmic transfer, is an outside the body, in vitro fertilization (IVF) technique. Ooplasmic transfer in humans (Homo sapiens) is similar to in vitro fertilization (IVF), with a few additions. IVF is the process in which doctors manually combine an egg and sperm cells in a laboratory dish, as opposed to artificial insemination, which takes place in the female's body. For ooplasmic transfer, doctors withdraw cytoplasm from a donor's oocyte, and then they inject that cytoplasm with sperm into a patient's oocyte.
Format: Articles
Subject: Technologies
The e-Mouse Atlas Project (1992- )
The Edinburgh Mouse Atlas, also called the e-Mouse Atlas Project (EMAP), is an online resource comprised of the e-Mouse Atlas (EMA), a detailed digital model of mouse development, and the e-Mouse Atlas of Gene Expression (EMAGE), a database that identifies sites of gene expression in mouse embryos. Duncan Davidson and Richard Baldock founded the project in 1992, and the Medical Research Council (MRC) in Edinburgh, United Kingdom, funds the project.
Format: Articles
Subject: Technologies
Copper Intrauterine Device (IUD)
The copper intrauterine device, or IUD, is a long-term, reversible contraceptive first introduced by Howard Tatum and Jamie Zipper in 1967. Health care providers place an IUD inside a woman’s uterus to prevent pregnancy. Copper IUDs are typically made of T-shaped plastic with some portion covered with exposed copper. Prior to the invention of the first IUDs, women had few long-term options for safe and reliable birth control. Those options mostly consisted of barrier methods and the oral birth control pill, which were only effective if used correctly and consistently.
Format: Articles
Subject: Technologies
The Shettles Method of Sex Selection
In the 1960s in the United States Landrum B. Shettles developed the Shettles method, which is a procedure for couples to use prior to and during an intercourse to increase their chances of conceiving a fetus of their desired sex. Shettles, a physician, who specialized in obstetrics and gynecology, found a difference in the size and shape of male sperm cells that he correlated with the different sex chromosomes they carry.
Format: Articles
Subject: Technologies, Reproduction
Noninvasive Fetal Aneuploidy Detection for Trisomy 21, 13, and 18
Noninvasive fetal aneuploidy detection technology allows for the detection of fetal genetic conditions, specifically having three chromosomes, a condition called aneuploidy, by analyzing a simple blood sample from the pregnant woman. Dennis Lo and Rossa Chiu researched methods of detection of aneuploidies in the early twenty-first century. Their research has been specifically applied to three trisomies, trisomy twenty-one known as Down syndrome, trisomy eighteen known as Edwards Syndrome, and trisomy thirteen known as Patau Syndrome.
Format: Articles
Subject: Technologies
MicroSort
"MicroSort, developed in 1990 by the Genetics and IVF Institute, is a form of pre-conception sex selection technology for humans. Laboratories located around the world use MicroSort technology to help couples increase their chances of conceiving a child of their desired sex. MicroSort separates male sperm cells based on which sex chromosome they contain, which results in separated semen samples that contain a higher percentage of sperm cells that carry the same sex chromosome.
Format: Articles
Subject: Technologies